- Home
- IPHA vs EVC Comparison
IPHA vs EVC Comparison
Compare IPHA & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- EVC
- Stock Information
- Founded
- IPHA 1999
- EVC 1996
- Country
- IPHA France
- EVC United States
- Employees
- IPHA N/A
- EVC N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- EVC Broadcasting
- Sector
- IPHA Health Care
- EVC Industrials
- Exchange
- IPHA Nasdaq
- EVC Nasdaq
- Market Cap
- IPHA 160.1M
- EVC 188.3M
- IPO Year
- IPHA 2019
- EVC 2000
- Fundamental
- Price
- IPHA $1.75
- EVC $2.48
- Analyst Decision
- IPHA Strong Buy
- EVC
- Analyst Count
- IPHA 1
- EVC 0
- Target Price
- IPHA $11.00
- EVC N/A
- AVG Volume (30 Days)
- IPHA 11.1K
- EVC 355.1K
- Earning Date
- IPHA 03-27-2025
- EVC 08-07-2025
- Dividend Yield
- IPHA N/A
- EVC 8.06%
- EPS Growth
- IPHA N/A
- EVC N/A
- EPS
- IPHA N/A
- EVC N/A
- Revenue
- IPHA $20,831,349.00
- EVC $378,623,000.00
- Revenue This Year
- IPHA $209.83
- EVC $64.06
- Revenue Next Year
- IPHA $83.15
- EVC N/A
- P/E Ratio
- IPHA N/A
- EVC N/A
- Revenue Growth
- IPHA N/A
- EVC 23.10
- 52 Week Low
- IPHA $1.29
- EVC $1.58
- 52 Week High
- IPHA $3.51
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- IPHA 34.48
- EVC 64.67
- Support Level
- IPHA $1.71
- EVC $2.19
- Resistance Level
- IPHA $1.90
- EVC $2.53
- Average True Range (ATR)
- IPHA 0.08
- EVC 0.10
- MACD
- IPHA -0.00
- EVC 0.01
- Stochastic Oscillator
- IPHA 18.96
- EVC 85.71
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.